Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1945 1
1947 2
1951 1
1955 1
1956 1
1957 2
1958 1
1964 1
1965 2
1967 2
1968 2
1969 3
1970 3
1971 2
1972 1
1974 2
1975 1
1976 1
1977 2
1978 8
1979 7
1981 6
1982 3
1983 1
1984 16
1985 13
1986 25
1987 22
1988 21
1989 9
1990 21
1991 22
1992 20
1993 21
1994 27
1995 21
1996 40
1997 31
1998 32
1999 28
2000 33
2001 38
2002 51
2003 51
2004 64
2005 74
2006 69
2007 65
2008 77
2009 90
2010 113
2011 94
2012 86
2013 113
2014 145
2015 144
2016 150
2017 150
2018 142
2019 148
2020 160
2021 181
2022 18
Text availability
Article attribute
Article type
Publication date

Search Results

2,403 results
Results by year
Filters applied: . Clear all
Page 1
Effect of a plant-based, low-fat diet versus an animal-based, ketogenic diet on ad libitum energy intake.
Hall KD, Guo J, Courville AB, Boring J, Brychta R, Chen KY, Darcey V, Forde CG, Gharib AM, Gallagher I, Howard R, Joseph PV, Milley L, Ouwerkerk R, Raisinger K, Rozga I, Schick A, Stagliano M, Torres S, Walter M, Walter P, Yang S, Chung ST. Hall KD, et al. Among authors: walter m. Nat Med. 2021 Feb;27(2):344-353. doi: 10.1038/s41591-020-01209-1. Epub 2021 Jan 21. Nat Med. 2021. PMID: 33479499 Clinical Trial.
Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake.
Hall KD, Ayuketah A, Brychta R, Cai H, Cassimatis T, Chen KY, Chung ST, Costa E, Courville A, Darcey V, Fletcher LA, Forde CG, Gharib AM, Guo J, Howard R, Joseph PV, McGehee S, Ouwerkerk R, Raisinger K, Rozga I, Stagliano M, Walter M, Walter PJ, Yang S, Zhou M. Hall KD, et al. Among authors: walter m. Cell Metab. 2019 Jul 2;30(1):67-77.e3. doi: 10.1016/j.cmet.2019.05.008. Epub 2019 May 16. Cell Metab. 2019. PMID: 31105044 Free PMC article. Clinical Trial.
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.
Malcovati L, Stevenson K, Papaemmanuil E, Neuberg D, Bejar R, Boultwood J, Bowen DT, Campbell PJ, Ebert BL, Fenaux P, Haferlach T, Heuser M, Jansen JH, Komrokji RS, Maciejewski JP, Walter MJ, Fontenay M, Garcia-Manero G, Graubert TA, Karsan A, Meggendorfer M, Pellagatti A, Sallman DA, Savona MR, Sekeres MA, Steensma DP, Tauro S, Thol F, Vyas P, Van de Loosdrecht AA, Haase D, Tüchler H, Greenberg PL, Ogawa S, Hellstrom-Lindberg E, Cazzola M. Malcovati L, et al. Among authors: walter mj. Blood. 2020 Jul 9;136(2):157-170. doi: 10.1182/blood.2020004850. Blood. 2020. PMID: 32347921 Free PMC article. Review.
Role of inflammation in depression relapse.
Liu CH, Zhang GZ, Li B, Li M, Woelfer M, Walter M, Wang L. Liu CH, et al. Among authors: walter m. J Neuroinflammation. 2019 Apr 17;16(1):90. doi: 10.1186/s12974-019-1475-7. J Neuroinflammation. 2019. PMID: 30995920 Free PMC article. Review.
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation.
Christopher MJ, Petti AA, Rettig MP, Miller CA, Chendamarai E, Duncavage EJ, Klco JM, Helton NM, O'Laughlin M, Fronick CC, Fulton RS, Wilson RK, Wartman LD, Welch JS, Heath SE, Baty JD, Payton JE, Graubert TA, Link DC, Walter MJ, Westervelt P, Ley TJ, DiPersio JF. Christopher MJ, et al. Among authors: walter mj. N Engl J Med. 2018 Dec 13;379(24):2330-2341. doi: 10.1056/NEJMoa1808777. Epub 2018 Oct 31. N Engl J Med. 2018. PMID: 30380364 Free PMC article.
U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies.
Smith MA, Choudhary GS, Pellagatti A, Choi K, Bolanos LC, Bhagat TD, Gordon-Mitchell S, Von Ahrens D, Pradhan K, Steeples V, Kim S, Steidl U, Walter M, Fraser IDC, Kulkarni A, Salomonis N, Komurov K, Boultwood J, Verma A, Starczynowski DT. Smith MA, et al. Among authors: walter m. Nat Cell Biol. 2019 May;21(5):640-650. doi: 10.1038/s41556-019-0314-5. Epub 2019 Apr 22. Nat Cell Biol. 2019. PMID: 31011167 Free PMC article.
Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity.
O'Mara AE, Johnson JW, Linderman JD, Brychta RJ, McGehee S, Fletcher LA, Fink YA, Kapuria D, Cassimatis TM, Kelsey N, Cero C, Sater ZA, Piccinini F, Baskin AS, Leitner BP, Cai H, Millo CM, Dieckmann W, Walter M, Javitt NB, Rotman Y, Walter PJ, Ader M, Bergman RN, Herscovitch P, Chen KY, Cypess AM. O'Mara AE, et al. Among authors: walter m. J Clin Invest. 2020 May 1;130(5):2209-2219. doi: 10.1172/JCI131126. J Clin Invest. 2020. PMID: 31961826 Free PMC article. Clinical Trial.
2,403 results